Kevin Schwartz

Adjunct Scientist (Full Status)

ICES Affiliation

ICES UofT
Populations & Public Health Research Program

Phone
647-260-7629

Biography

Contact Kevin Schwartz

@kevin_kls

Education

Diploma in Tropical Medicine and Hygiene, The Gorgas Course of Tropical Medicine
FRCPC, Infectious Diseases, University of Toronto
FRCPC, Pediatrics, University of Calgary
MSc, Clinical Epidemiology, University of Toronto
MD, University of Toronto

Research Focus

Drug prescribing behaviour
Infectious diseases

Other Affiliations

Infection Prevention and Control (IPAC) and Antimicrobial Stewardship Physician, Public Health Ontario
Assistant Professor, Dalla Lana School of Public Health, University of Toronto
Infectious Disease Consultant, St. Joseph's Health Centre

Recent ICES Grants

Incidence and risk factors of inappropriate antibiotic prescribing and related adverse health outcomes among Ontario long-term care residents and marginalized older community-dwelling adults with COVID-19 (I-CARE)

Principal investigators: Daneman N, MacFadden DR, Maxwell CJ, Mishra S, Schwartz KL
Co-investigators: Brooks JI, Bowdish DM, Bronskill SE, Burrows LL, Langford BJ, Leung E, Leung V, Manuel DG, McGeer AJ, Morris AM, Nott C, Raybardhan S, So M, Soucy J
Canadian Institutes of Health Research, Operating Grant
2021-2022; $308,904
The prevention of group B streptococcal (GBS) disease in infants

Principal investigators: Crowcroft N, Fell D, Sander B
Co-investigators: Barrett J, Bolotin S, Brown KA, Fittipaldi NV, Mcgeer AJ, Murti M, Sadarangani M, Schwartz KL, Wilson K
Canadian Institutes of Health Research, Project Grant
2019-2022; $409,276
Comprehensive Ontario Microbiology laBoratory Administrative daTa for AntiMicrobial Resistance (COMBAT-AMR)

Principal investigators: Brown KA, Daneman N
Co-investigators: Sander B, Schwartz KL, Stukel T
Canadian Institutes of Health Research, Project Scheme Grant
2018-2021; $608,176

Recent ICES Publications

9/22/2022

Estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes

Buchan SA, Chung H, Brown KA, Austin PC, Fell DB, Gubbay JB, Nasreen S, Schwartz KL, Sundaram ME, Tadrous M, Wilson K, Wilson SE, Kwong JC. JAMA Netw Open. 2022; 5(9):e2232760. Epub 2022 Sep 22. DOI: https://doi.org/10.1001/jamanetworkopen.2022.32760

9/7/2022

Effectiveness of COVID-19 vaccines over time prior to Omicron emergence in Ontario, Canada: test-negative design study

Chung H, Austin PC, Brown KA, Buchan SA, Fell DB, Fong C, Gubbay JB, Nasreen S, Schwartz KL, Sundaram ME, Tadrous M, Wilson K, Wilson SE, Kwong JC; on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Open Forum Infect Dis. 2022; Sep 7 [Epub ahead of print]. DOI: https://doi.org/10.1093/ofid/ofac449

7/26/2022

A time series analysis evaluating antibiotic prescription rates in long-term care during the COVID-19 pandemic in Alberta and Ontario, Canada

Haverkate MR, Macfadden DR, Daneman N, Leal J, Otterstatter M, Mahdavi R, D’Souza AG, Rennert-May E, Silverman M, Schwartz KL, Morris AM, Saatchi A, Patrick DM, Marra F. Antibiotics (Basel). 2022; 11(8):1001. Epub 2022 Jul 26. DOI: https://doi.org/10.3390/antibiotics11081001

See more ICES Publications

News coverage

Healthline.com12/10/2018Article